A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2002
10/24/2002	US20020156033 Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer
10/24/2002	US20020156023 Lometrexol combination therapy
10/24/2002	US20020156017 Antimicrobial peptides and methods of use thereof
10/24/2002	US20020156013 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
10/24/2002	US20020156001 Novel fibroblast growth factor ( FGF23) and methods for use
10/24/2002	US20020155577 Compound for use in the treatment of parkinson's disease
10/24/2002	US20020155572 Peptide for use in diagnosis and treatment of alzheimier's disease
10/24/2002	US20020155562 Glutathionylspermidine synthetase and processes for recovery and use thereof
10/24/2002	US20020155534 SBHWSB2: a new member of the WD40 SOCS box family
10/24/2002	US20020155528 Regulation of human CysLT2-like GPCR protein
10/24/2002	US20020155527 Nucleotide sequences coding membrane protein for use in the treatment of tumors
10/24/2002	US20020155503 Method for mapping the active sites bound by enzymes that covalently modify substrate molecules
10/24/2002	US20020155432 Genetically engineered herpes virus for the treatment of cardiovascular disease
10/24/2002	US20020155431 Screenining and detection of antiproliferative agentst; obtain tumor cells, incubate with antiproliferative agents, monitor reduction in tumor activity
10/24/2002	US20020155426 Prevention and treatment of amyloid-associated disorders
10/24/2002	US20020155170 Detoxification of heavy metals; adjustment concentration of metallothionein
10/24/2002	US20020155165 Method for treating renal disease, and pharmaceutical composition for treating renal disease
10/24/2002	US20020155163 Integrated multi-vitamin and mineral combination
10/24/2002	US20020155153 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID
10/24/2002	US20020155144 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
10/24/2002	US20020155123 Compositions and methods for inhibiting HIV infection
10/24/2002	US20020155103 Activated charcoal based composition and method for reducing hangover symptomps associated with the consumption of alcohol containing beverages
10/24/2002	US20020155102 Administering to a mammal formulation of cationic lipids and a substance that affects angiogenesis; allowing formulation to associate with angiogenic endothelial cells of an angiogenic blood vesselsuch that it enters cells
10/24/2002	US20020155097 For therapy and prophylaxis of cancer and tumors
10/24/2002	US20020155066 For pulmonary administration of highly toxic or vesicating anticancer drugs
10/24/2002	DE10113185A1 Zusammensetzung, enthaltend einen Gallium(III)-Komplex und einen therapeutisch wirksamen Platin-Komplex A composition comprising a gallium (III) complex and a therapeutically effective platinum complex
10/24/2002	CA2763637A1 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
10/24/2002	CA2446093A1 Methods of preventing uvb-induced skin damage
10/24/2002	CA2445990A1 Full-length human cdnas encoding potentially secreted proteins
10/24/2002	CA2444932A1 Aromatase inhibition to enhance assisted reproduction
10/24/2002	CA2444632A1 Vascular endothelial growth factor 2
10/24/2002	CA2444548A1 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/24/2002	CA2444518A1 Biomaterials comprising a melanocyte stimulating hormone (msh), and method of forming
10/24/2002	CA2444481A1 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method
10/24/2002	CA2444465A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method
10/24/2002	CA2444421A1 Modification of the sustained release profile
10/24/2002	CA2444377A1 Method of intradermally injecting substances
10/24/2002	CA2444267A1 Prodrugs of cox-2 inhibitors
10/24/2002	CA2444264A1 Prodrugs via acylation with cinnamate
10/24/2002	CA2444220A1 Orally deliverable pharmaceutical composition comprising a drug of low water solubility (cox-2 inhibitor), a solvent, a fatty acid and an organic amine
10/24/2002	CA2444047A1 Methods to inhibit viral replication
10/24/2002	CA2443995A1 Endothelial cell expression patterns
10/24/2002	CA2443900A1 Methods of treating prion disease in mammals comprising administering a chaotropic agent such as guanidine, urea or potassium iodide
10/24/2002	CA2443897A1 Transporters and ion channels
10/24/2002	CA2443655A1 Tropane alkaloid multidrug resistance inhibitors from erythroxylum pervillei and use of the same
10/24/2002	CA2443639A1 Compositions containing imidazotriazinone for nasal application
10/24/2002	CA2443559A1 Compositions containing cgmp pde inhibitors and local anaesthetic agents for nasal application
10/24/2002	CA2443525A1 Human cellular protein gastrointestinal glutathione peroxidase as target for medical intervention against hepatitis c virus infections
10/24/2002	CA2443408A1 Kinases and phosphatases
10/24/2002	CA2443244A1 Enzymes
10/24/2002	CA2443229A1 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv
10/24/2002	CA2442264A1 A method of treating cancer
10/24/2002	CA2441274A1 Aurones as telomerase inhibitors
10/23/2002	EP1251137A2 Use of insulin-like growth factor agonist peptides
10/23/2002	EP1251128A1 Cyclohexylamine derivatives as subtype selective N-methyl-D-aspartate antagonists
10/23/2002	EP1250934A1 Anticancer compositions
10/23/2002	EP1250927A2 Pharmaceutical composition for topical application comprising nifedipine
10/23/2002	EP1250923A2 Use of selective PDE10 inhibitors for the treatment of central nervous system disorders
10/23/2002	EP1250600A2 Diagnosis of tauopathies determining tau/phospho-tau ratio
10/23/2002	EP1250432A2 Nuclear hormone receptors
10/23/2002	EP1250356A2 POTASSIUM CHANNEL MUTANTS OF THE i SACCHAROMYCES CEREVISIAE /i YEAST AND THE USE THEREOF FOR THE SCREENING OF EUKARYOTIC POTASSIUM CHANNELS
10/23/2002	EP1250340A1 Methods and compounds for inhibiting mrp1
10/23/2002	EP1250321A1 Glyburide composition
10/23/2002	EP1250152A1 Hyaluronic acid in the treatment of cancer
10/23/2002	EP1250149A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer
10/23/2002	EP1250146A2 Use of neurotoxins for treating diabetes
10/23/2002	EP1250142A1 Multivalent electron active compositions and methods of making and using same
10/23/2002	EP1250140A2 Combinations of a receptor tyrosine kinase inhibitor with alpha1-acidic glycoprotein binding compound
10/23/2002	EP1250139A1 Product for treating gynecomastia
10/23/2002	EP1250137A2 Jak/stat pathway inhibitors and the uses thereof
10/23/2002	EP1250135A1 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
10/23/2002	EP1250134A1 Compositions for the prevention of diaper dermatitis
10/23/2002	EP1250132A1 Ibuprofen containing active agent preparation
10/23/2002	EP1250131A2 Modulation of the blood-brain barrier transporter for leptin
10/23/2002	EP1250128A2 Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage
10/23/2002	EP1250124A2 Slimming cosmetic composition comprising as active agent a plant extract containing a plant natriuretic peptide (pnp)
10/23/2002	EP1250116A1 Pharmaceutical and cosmetic carrier or composition for topical application
10/23/2002	EP1140191B1 Combinations of ileal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indications
10/23/2002	EP0750510B1 Anti-acne skin treatment composition
10/23/2002	CN1376146A Solid-state form of celecoxil having enhanced bioavailability
10/23/2002	CN1376072A Metabolic intervention with GLP-1 or its biologically active analygues to improve the function of the ischemic and reperfused brain
10/23/2002	CN1376070A Method for the therapeutic management of extrauterine prolifieration of endometrical tissue, chronic pelvic pain and fallopian tube obstruction
10/23/2002	CN1376067A Conditioned cell culture medium compositions and method of use
10/23/2002	CN1376066A Use of H1 antagonist and a safe steroid to treat eye conditions
10/23/2002	CN1376065A Compositions having improved stability
10/23/2002	CN1376055A Aerosol ointment compositions and method of manufacture
10/23/2002	CN1376054A Topcial suspension formulations containing ciprofloxacin and dexa methasone
10/23/2002	CN1092960C Pharmaceutical composition comprising proteinase inhibitor and monoglyceride
10/23/2002	CA2383149A1 Process for partially reducing or eliminating the symptoms associated with the release of histamine in the body
10/23/2002	CA2383115A1 Use of an effective amount of at least one ion chelating agent to enhance the tolerance level of sensitive or intolerant skin
10/23/2002	CA2381630A1 Method for preventing dyskinesias
10/22/2002	WO2001091753A1 Active substance combination containing an opioid having a fentanyl-type structure and ketamine
10/22/2002	US6469066 Treating burns with one or more of acetic acid, vinegar and citric acid for prevention of delayed hyperalgesia
10/22/2002	US6469065 Compound that donates, transfers or releases nitric oxide, elevates endogenous levels of nitric oxide
10/22/2002	US6469061 Use of members of the plant stress hormone family termed ?jasmonates?, for suppressing and killing mammalian cancer cells that represent major types of human malignancies
10/22/2002	US6469058 For the treatment of nonsmall cell lung cancer
10/22/2002	US6469055 Modulating expression, production, or formation of amyloid precursor protein by administering a nonsteroidal antiinflammatory agent that is a cyclooxygenase inhibitor
10/22/2002	US6469027 N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis
10/22/2002	US6469024 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
10/22/2002	US6469016 Treatment of female sexual dysfunction using phosphodiesterase inhibitors

1 ... 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 ... 1151